Lumida
/TOI
⌘K
Oncology Institute Inc

Oncology Institute Inc

TOI
$5.35USD+1.71%+0.09 today

MARKET CAP

534.9M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$2
$7

AI Summary

Stalk
Sell NowMedium

TOI is entrenched in a Stage 4 decline within a longer-term uptrend, having broken key multi-month support and triggering active bearish patterns. Price remains below the declining 9- and 21-EMAs with no sign of repair, confirming medium-term bearish control. Short-term conditions are unfavorable for longs, and any minor retracement toward the falling EMAs is likely resistance. Execution favors immediate participation in the breakdown continuation.

  • Q1 revenue $147M, up 41% YoY, fueled by pharmacy growth.
  • Specialty pharmacy revenue $87.5M, +77.6% YoY, diversifying income.
  • Earnings yield -0.97 indicates difficulty converting revenue to profit.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND